准PCNA/PARP1轴可以抑制肝细胞癌的恶性进展
Jipin Li1,2, Tao Yong1,2, Yali Chen2
1Department of General Surgery, The Second Hospital of Lanzhou University, Lanzhou, China.
Frontiers in pharmacology
|May 2, 2025
概括
向增殖细胞核抗原 (PCNA) 和多 (ADP-ribose) 聚合酶1 (PARP1) 抑制了肝细胞癌 (HCC) 的生长. 抑制PCNA增强了Olaparib的敏感性,为HCC提供了一个新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 增殖细胞核抗原 (PCNA) 与癌症进展和肝细胞癌 (HCC) 的预后不佳有关.
- PCNA在HCC发育中的确切作用,特别是它与DNA修复途径的相互作用,仍然不清楚.
- 了解PCNA的机制对于开发向的HCC疗法至关重要.
研究的目的:
- 研究PCNA如何影响HCC的DNA损伤修复和细胞周期进展.
- 探索PCNA和HCC中的多 (ADP-ribose) 聚合酶1 (PARP1) 之间的相互作用.
- 评估向PCNA/PARP1轴在HCC中的治疗潜力.
主要方法:
- 在HCC细胞系中,PCNA在遗传和药理上被抑制.
- 使用共免疫沉和功能测定证实了PCNA-PARP1相互作用.
- 对PARP1抑制剂Olaparib的HCC细胞敏感性在PCNA抑制下进行了评估.
- 对PCNA抑制剂AOH1160和Olaparib的协同效应进行了体外和体内评估.
- 分析了TCGA数据集,以将PCNA表达与HCC预后相关联.
主要成果:
- 抑制PCNA导致DNA损伤修复受损,并诱导HCC细胞的细胞循环停止.
- PARP1被确定为与PCNA相互作用的直接下游目标.
- PCNA抑制使HCC细胞对Olaparib敏感,AOH1160和Olaparib显示出协同的抗增殖作用.
- 升高的PCNA水平与HCC预后不佳相关.
- 在体内,PCNA/PARP1轴的联合抑制显著降低了HCC瘤的生长.
结论:
- PCNA/PARP1轴在HCC进展,DNA损伤修复和细胞周期调节方面发挥着至关重要的作用.
- 在HCC中,PCNA作为潜在的治疗生物标志物.
- 针对PCNA/PARP1轴,特别是PCNA和PARP1抑制剂的组合,为HCC提供了一个有前途的治疗策略.
相关概念视频
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Interactions Between Signaling Pathways
6.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.1K
Abnormal Proliferation
4.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
Tumor Progression
6.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.1K
DNA Damage can Stall the Cell Cycle
9.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K


